About Us

Last update: June 7th, 2026.

Who we Are: Precision Software Development for Longevity

Blueberry Diagnostics is a biotechnology company specialized in developing high-precision software for evidence-based science, early detection, cancer prevention, and longevity. We translate the complexity of biomedical laboratory data into clear, actionable, and understandable roadmaps, giving individuals back proactive control over their health and their true biological life expectancy.

Our Story: The Healthcare Challenge of Our Generation

Blueberry Diagnostics was born out of a profound concern over an alarming reality: for the first time in modern history, current generations face the risk of a shorter life expectancy and a poorer quality of life than their parents. The rise of Cardiovascular-Kidney-Metabolic (CKM) Syndrome —which already affects nearly 90% of the U.S. adult population— combined with a purely reactive traditional medical model, accelerates the onset of perfectly preventable chronic diseases, including cancer.

Faced with this crisis, we decided to step in. We founded the company with the firm purpose of breaking this cycle, using technology and advanced algorithmic analysis to intercept risk vectors in their subclinical phase, long before the first physical symptoms manifest in the patient.

Our Identity: The Fundamental Pillars

Our daily activities and our scientific developments are strictly guided by a transparent, accessible, and rigorous corporate philosophy. The three independent pillars that define our overall purpose are:

Leadership, Scientific Endorsement, and Global Presence

Behind each of our diagnostic algorithms and specialized tests —such as the Venient Fx, Venient Cx, Venient Sx, and Venient CDx test families—, is a multidisciplinary team of healthcare professionals, software developers, and data scientists. True to the principles of Evidence-Based Medicine (EBM) and Evidence-Based Laboratory Medicine (EBLM), our team not only applies existing science but actively generates it.

We regularly publish the results of our own research and clinical studies in the most prestigious international medical congresses within the healthcare sector, ensuring the utmost scientific rigor in every development. From our headquarters in Barcelona (Spain), we design and coordinate biotechnological solutions with a clear international focus to universalize precision medicine.